W.H.O. Announces Trial to Test Remdisivir, Used Against Coronavirus, to Fight Ebola in DR Congo

The World Health Organization is set to test the antiviral drug Remdesivir, which has shown promise in treating COVID-19, for its potential efficacy against the Ebola Bundibugyo virus in the Democratic Republic of Congo. This move underscores the urgency and scale of the Ebola outbreak in the region, as the W.H.O. seeks innovative solutions beyond traditional treatments. The trial's implications could reshape how future outbreaks are managed, especially if Remdesivir proves effective against Ebola, offering a new weapon in the fight against deadly viruses.